Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 229 to 230 of 230 entries
Sorted by: Best Match Show Resources per page
Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot Program.

Clinical pharmacology and therapeutics

Galluppi GR, Brar S, Caro L, Chen Y, Frey N, Grimm HP, Rudd DJ, Li CC, Magee M, Mukherjee A, Nagao L, Purohit VS, Roy A, Salem AH, Sinha V, Suleiman AA, Taskar KS, Upreti VV, Weber B, Cook J.
PMID: 33991429
Clin Pharmacol Ther. 2021 Nov;110(5):1172-1175. doi: 10.1002/cpt.2265. Epub 2021 May 15.

No abstract available.

Cite
Galluppi GR, Brar S, Caro L, et al. Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot Program. Clin Pharmacol Ther. 2021;110(5):1172-1175doi: 10.1002/cpt.2265.
Galluppi, G. R., Brar, S., Caro, L., Chen, Y., Frey, N., Grimm, H. P., Rudd, D. J., Li, C. C., Magee, M., Mukherjee, A., Nagao, L., Purohit, V. S., Roy, A., Salem, A. H., Sinha, V., Suleiman, A. A., Taskar, K. S., Upreti, V. V., Weber, B., & Cook, J. (2021). Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot Program. Clinical pharmacology and therapeutics, 110(5), 1172-1175. https://doi.org/10.1002/cpt.2265
Galluppi, Gerald R, et al. "Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot Program." Clinical pharmacology and therapeutics vol. 110,5 (2021): 1172-1175. doi: https://doi.org/10.1002/cpt.2265
Galluppi GR, Brar S, Caro L, Chen Y, Frey N, Grimm HP, Rudd DJ, Li CC, Magee M, Mukherjee A, Nagao L, Purohit VS, Roy A, Salem AH, Sinha V, Suleiman AA, Taskar KS, Upreti VV, Weber B, Cook J. Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot Program. Clin Pharmacol Ther. 2021 Nov;110(5):1172-1175. doi: 10.1002/cpt.2265. Epub 2021 May 15. PMID: 33991429; PMCID: PMC8596613.
Copy Download .nbib Format: NLM
A practical guide to large-scale docking.

Nature protocols

Bender BJ, Gahbauer S, Luttens A, Lyu J, Webb CM, Stein RM, Fink EA, Balius TE, Carlsson J, Irwin JJ, Shoichet BK.
PMID: 34561691
Nat Protoc. 2021 Oct;16(10):4799-4832. doi: 10.1038/s41596-021-00597-z. Epub 2021 Sep 24.

Structure-based docking screens of large compound libraries have become common in early drug and probe discovery. As computer efficiency has improved and compound libraries have grown, the ability to screen hundreds of millions, and even billions, of compounds has...

Cite
Bender BJ, Gahbauer S, Luttens A, et al. A practical guide to large-scale docking. Nat Protoc. 2021;16(10):4799-4832doi: 10.1038/s41596-021-00597-z.
Bender, B. J., Gahbauer, S., Luttens, A., Lyu, J., Webb, C. M., Stein, R. M., Fink, E. A., Balius, T. E., Carlsson, J., Irwin, J. J., & Shoichet, B. K. (2021). A practical guide to large-scale docking. Nature protocols, 16(10), 4799-4832. https://doi.org/10.1038/s41596-021-00597-z
Bender, Brian J, et al. "A practical guide to large-scale docking." Nature protocols vol. 16,10 (2021): 4799-4832. doi: https://doi.org/10.1038/s41596-021-00597-z
Bender BJ, Gahbauer S, Luttens A, Lyu J, Webb CM, Stein RM, Fink EA, Balius TE, Carlsson J, Irwin JJ, Shoichet BK. A practical guide to large-scale docking. Nat Protoc. 2021 Oct;16(10):4799-4832. doi: 10.1038/s41596-021-00597-z. Epub 2021 Sep 24. PMID: 34561691; PMCID: PMC8522653.
Copy Download .nbib Format: NLM
Showing 229 to 230 of 230 entries